Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
National Metro Safety Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- Issues related to ensuring quality of supply chain for FDA regulated products - Issues generating antibiotic incentives - Issues regarding personalized medicine - Issues related to the Prescription Drug Use Fee Program - Issues related to the Medical Device User Fee Program. - Issues related to the Prescription Drugs User Fee Act - Issues related to the Better Act - Issues related to the Personalized Medicine Bill - S. 1001, "Safe Doses Act", regarding all provisions. - HR 1282, "Generating Antibiotics Incentives Now Act of 2011", regarding all provisions. - Issues related to the Regulation & Reimbursement of Diagnostics", regarding all provisions.
Alternative Fueled Vehicles Competitiveness and Energy Security Act of 2011
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2011 · second_quarter · Q2
- Issues related to ensuring quality of supply chain for FDA regulated products - Issues generating antibiotic incentives - Issues regarding personalized medicine - Issues related to the Prescription Drug Use Fee Program - Issues related to the Medical Device User Fee Program. - Issues related to the Prescription Drugs User Fee Act - Issues related to the Better Act - Issues related to the Personalized Medicine Bill - S. 1001, "Safe Doses Act", regarding all provisions. - HR 1282, "Generating Antibiotics Incentives Now Act of 2011", regarding all provisions. - Issues related to the Regulation & Reimbursement of Diagnostics", regarding all provisions.
Source: Senate LDA
- Issues related to ensuring quality of supply chain for FDA regulated products - Issues generating antibiotic incentives - Issues regarding personalized medicine - Issues related to the Prescription Drug Use Fee Program - Issues related to the Medical Device User Fee Program. - Issues related to the Prescription Drugs User Fee Act - Issues related to the Better Act - Issues related to the Personalized Medicine Bill - S. 1001, "Safe Doses Act", regarding all provisions. - HR 1282, "Generating Antibiotics Incentives Now Act of 2011", regarding all provisions. - Issues related to the Regulation & Reimbursement of Diagnostics", regarding all provisions.
Dextromethorphan Distribution Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions.
Dextromethorphan Distribution Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetamine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.
Dextromethorphan Distribution Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346/ S. 540, "Medical Device Safety Act of 2009", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications.
Dextromethorphan Distribution Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetimine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.
Access for All America Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 3397, "An Act to Amend the Controlled Substances Act to provide for take-back Disposal of Controlled Substances in certain instances and for other purposes", regarding all provisions.
Access for All America Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions.
Access for All America Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 3397, "An Act to Amend the Controlled Substances Act to provide for take-back Disposal of Controlled Substances in certain instances and for other purposes", regarding all provisions. - H.R. 6331, "Generating Antibiotic Incentives Now Act of 2010", regarding all provisions.
Access for All America Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - H.R. 3590, "An Act entitled The Patient Protection and Affordable Care Act", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 4872, "Health Care and Education Reconciliation Act of 2010", regarding all provisions.
Medical Device Safety Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions.
Medical Device Safety Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346/ S. 540, "Medical Device Safety Act of 2009", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications.
Medical Device Safety Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetamine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.
Medical Device Safety Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetimine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - H.R. 3590, "An Act entitled The Patient Protection and Affordable Care Act", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 4872, "Health Care and Education Reconciliation Act of 2010", regarding all provisions.
Pathway for Biosimilars Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - H.R. 3590, "An Act entitled The Patient Protection and Affordable Care Act", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 4872, "Health Care and Education Reconciliation Act of 2010", regarding all provisions.
Healthy Workforce Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - H.R. 3590, "An Act entitled The Patient Protection and Affordable Care Act", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 4872, "Health Care and Education Reconciliation Act of 2010", regarding all provisions.
Healthy Workforce Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions.
Comparative Effectiveness Research Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions.
Comparative Effectiveness Research Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetamine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.
Comparative Effectiveness Research Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346/ S. 540, "Medical Device Safety Act of 2009", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications.
Comparative Effectiveness Research Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetimine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.
Combat Methamphetamine Enhancement Act of 2010
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetimine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.
Combat Methamphetamine Enhancement Act of 2010
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetamine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.
To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner.
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions. - H.R. 3790, "To amend Title XVIII of the Social Security Act to repeal the Medicare competitive acquision program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner. - H.R. 5440, "The Genomics and Personalized Medicine Act of 2010", regarding all provisions. - H. R. 6331, "Generating Antibiotic Incentives Act of 2010", regarding all provisions.
To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner.
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions. - H.R. 3790, "To amend Title XVIII of the Social Security Act to repeal the Medicare competitive acquision program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner.
To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner.
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions. - H.R. 3790, "To amend Title XVIII of the Social Security Act to repeal the Medicare competitive acquision program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner. - H.R. 5440, "The Genomics and Personalized Medicine Act of 2010", regarding all provisions.
To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner.
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions. - H.R. 3790, "To amend Title XVIII of the Social Security Act to repeal the Medicare competitive acquision program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner. - H.R. 5440, "The Genomics and Personalized Medicine Act of 2010", regarding all provisions. - H. R. 6331, "Generating Antibiotic Incentives Act of 2010", regarding all provisions.
Genomics and Personalized Medicine Act of 2010
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions. - H.R. 3790, "To amend Title XVIII of the Social Security Act to repeal the Medicare competitive acquision program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner. - H.R. 5440, "The Genomics and Personalized Medicine Act of 2010", regarding all provisions. - H. R. 6331, "Generating Antibiotic Incentives Act of 2010", regarding all provisions.
Genomics and Personalized Medicine Act of 2010
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions. - H.R. 3790, "To amend Title XVIII of the Social Security Act to repeal the Medicare competitive acquision program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner. - H.R. 5440, "The Genomics and Personalized Medicine Act of 2010", regarding all provisions.
Genomics and Personalized Medicine Act of 2010
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions. - H.R. 3790, "To amend Title XVIII of the Social Security Act to repeal the Medicare competitive acquision program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner. - H.R. 5440, "The Genomics and Personalized Medicine Act of 2010", regarding all provisions. - H. R. 6331, "Generating Antibiotic Incentives Act of 2010", regarding all provisions.
Safe Cosmetics Act of 2010
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetamine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.
Safe Cosmetics Act of 2010
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetimine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.
Generating Antibiotic Incentives Now Act of 2010
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions. - H.R. 3790, "To amend Title XVIII of the Social Security Act to repeal the Medicare competitive acquision program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner. - H.R. 5440, "The Genomics and Personalized Medicine Act of 2010", regarding all provisions. - H. R. 6331, "Generating Antibiotic Incentives Act of 2010", regarding all provisions.
Generating Antibiotic Incentives Now Act of 2010
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 3397, "An Act to Amend the Controlled Substances Act to provide for take-back Disposal of Controlled Substances in certain instances and for other purposes", regarding all provisions. - H.R. 6331, "Generating Antibiotic Incentives Now Act of 2010", regarding all provisions.
Generating Antibiotic Incentives Now Act of 2010
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions. - H.R. 3790, "To amend Title XVIII of the Social Security Act to repeal the Medicare competitive acquision program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner. - H.R. 5440, "The Genomics and Personalized Medicine Act of 2010", regarding all provisions. - H. R. 6331, "Generating Antibiotic Incentives Act of 2010", regarding all provisions.
Food and Drug Administration Globalization Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - H.R. 3590, "An Act entitled The Patient Protection and Affordable Care Act", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 4872, "Health Care and Education Reconciliation Act of 2010", regarding all provisions.
Food and Drug Administration Globalization Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 3397, "An Act to Amend the Controlled Substances Act to provide for take-back Disposal of Controlled Substances in certain instances and for other purposes", regarding all provisions.
Food and Drug Administration Globalization Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions.
Food and Drug Administration Globalization Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 3397, "An Act to Amend the Controlled Substances Act to provide for take-back Disposal of Controlled Substances in certain instances and for other purposes", regarding all provisions. - H.R. 6331, "Generating Antibiotic Incentives Now Act of 2010", regarding all provisions.
Informed Health Care Decision Making Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetimine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.
Informed Health Care Decision Making Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetamine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.
Informed Health Care Decision Making Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346/ S. 540, "Medical Device Safety Act of 2009", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications.
Informed Health Care Decision Making Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions.
Dextromethorphan Abuse Reduction Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetamine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.
Dextromethorphan Abuse Reduction Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions.
Dextromethorphan Abuse Reduction Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346/ S. 540, "Medical Device Safety Act of 2009", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications.
Dextromethorphan Abuse Reduction Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetimine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.
Physician Payments Sunshine Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions. - H.R. 3790, "To amend Title XVIII of the Social Security Act to repeal the Medicare competitive acquision program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner. - H.R. 5440, "The Genomics and Personalized Medicine Act of 2010", regarding all provisions. - H. R. 6331, "Generating Antibiotic Incentives Act of 2010", regarding all provisions.
Physician Payments Sunshine Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions. - H.R. 3790, "To amend Title XVIII of the Social Security Act to repeal the Medicare competitive acquision program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner.
Physician Payments Sunshine Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions. - H.R. 3790, "To amend Title XVIII of the Social Security Act to repeal the Medicare competitive acquision program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner. - H.R. 5440, "The Genomics and Personalized Medicine Act of 2010", regarding all provisions. - H. R. 6331, "Generating Antibiotic Incentives Act of 2010", regarding all provisions.
Physician Payments Sunshine Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions. - H.R. 3790, "To amend Title XVIII of the Social Security Act to repeal the Medicare competitive acquision program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner. - H.R. 5440, "The Genomics and Personalized Medicine Act of 2010", regarding all provisions.
Secure and Responsible Drug Disposal Act of 2010
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 3397, "An Act to Amend the Controlled Substances Act to provide for take-back Disposal of Controlled Substances in certain instances and for other purposes", regarding all provisions.
Secure and Responsible Drug Disposal Act of 2010
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 3397, "An Act to Amend the Controlled Substances Act to provide for take-back Disposal of Controlled Substances in certain instances and for other purposes", regarding all provisions. - H.R. 6331, "Generating Antibiotic Incentives Now Act of 2010", regarding all provisions.
Medical Device Safety Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346/ S. 540, "Medical Device Safety Act of 2009", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications.
Medical Device Safety Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetamine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.
Medical Device Safety Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetimine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.
Medical Device Safety Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - H.R. 3590, "An Act entitled The Patient Protection and Affordable Care Act", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 4872, "Health Care and Education Reconciliation Act of 2010", regarding all provisions.
Healthy Workforce Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions.
Healthy Workforce Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - H.R. 3590, "An Act entitled The Patient Protection and Affordable Care Act", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 4872, "Health Care and Education Reconciliation Act of 2010", regarding all provisions.
Drug and Device Accountability Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetimine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.
Drug and Device Accountability Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346/ S. 540, "Medical Device Safety Act of 2009", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications.
Drug and Device Accountability Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions.
Drug and Device Accountability Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetamine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.
American Middle Class Tax (AMT) Relief Act of 2007
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - H.R. 3590, "An Act entitled The Patient Protection and Affordable Care Act", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 4872, "Health Care and Education Reconciliation Act of 2010", regarding all provisions.
Superfund Polluter Pays Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - H.R. 3590, "An Act entitled The Patient Protection and Affordable Care Act", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 4872, "Health Care and Education Reconciliation Act of 2010", regarding all provisions.
Superfund Polluter Pays Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 3397, "An Act to Amend the Controlled Substances Act to provide for take-back Disposal of Controlled Substances in certain instances and for other purposes", regarding all provisions. - H.R. 6331, "Generating Antibiotic Incentives Now Act of 2010", regarding all provisions.
Superfund Polluter Pays Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 3397, "An Act to Amend the Controlled Substances Act to provide for take-back Disposal of Controlled Substances in certain instances and for other purposes", regarding all provisions.
Superfund Polluter Pays Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions.
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- S. Con. Res. 13, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2010, revising the appropriate budgetary levels for fiscal year 2009, and setting forth the appropriate budgetary levels for fiscal years 2011 through 2014.", regarding all provisions. - H. Con. Res. 85, "Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.", regarding all provisions.
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
-S. 1, "A bill to create jobs, restore economic growth, and strengthen America's middle class through measures that modernize the nation's infrastructure, enhance America's energy independence, expand educational opportunities, preserve and improve affordable health care, provide tax relief, and protect those in greatest need, and for other purposes", regarding all provisions. - H.R. 1, "Making supplemental appropriations for job preservation and creation, infrastructure investment, energy efficiency and science, assistance to the unemployed, and State and local fiscal stabilization, for fiscal year ending September 30, 2009, and for other purposes", regarding all provisions. - S. Con. Res. 13, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2010, revising the appropriate budgetary levels for fiscal year 2009, and setting forth the appropriate budgetary levels for fiscal years 2011 through 2014.", regarding all provisions. - H. Con. Res. 85, "Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.", regarding all provisions.
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- S. Con. Res. 13, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2010, revising the appropriate budgetary levels for fiscal year 2009, and setting forth the appropriate budgetary levels for fiscal years 2011 through 2014.", regarding all provisions. - H. Con. Res. 85, "Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.", regarding all provisions.
Dextromethorphan Distribution Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions.
Dextromethorphan Distribution Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions.
Dextromethorphan Distribution Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions.
Dextromethorphan Distribution Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions.
Dextromethorphan Distribution Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions.
Access for All America Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 2 / S. 275, "To amend title XXI of the Social Security Act to extend and improve the Children's Health Insurance Program, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - Issues relating to the "Comparative Effectiveness Research Act of 2008", regarding all provisions. - "Affordable Health Choices Act- To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. - House Energy & Commerce Committee Discussion Draft, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3200, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - Chairman's Mark, "America's Healthy Future Act of 2009", (bill not yet introduced), regarding all provisions.
Access for All America Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 2 / S. 275, "To amend title XXI of the Social Security Act to extend and improve the Children's Health Insurance Program, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - Issues relating to the "Comparative Effectiveness Research Act of 2008", regarding all provisions. -"Affordable Health Choices Act- To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. -House Energy & Commerce Committee Discussion Draft, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions.
Access for All America Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 1679, "To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. - S.1796, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3200, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3590, "An Act entitled The Patient Protection and Affordable Care Act", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in helaht care spending, and for other purposes.
Access for All America Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 1679, "To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. - S.1796, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3200, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3590, "An Act entitled The Patient Protection and Affordable Care Act", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in helaht care spending, and for other purposes.
Medical Device Safety Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions.
Medical Device Safety Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions.
Medical Device Safety Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions.
Medical Device Safety Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions.
Medical Device Safety Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 2 / S. 275, "To amend title XXI of the Social Security Act to extend and improve the Children's Health Insurance Program, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - Issues relating to the "Comparative Effectiveness Research Act of 2008", regarding all provisions. -"Affordable Health Choices Act- To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. -House Energy & Commerce Committee Discussion Draft, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 1679, "To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. - S.1796, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3200, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3590, "An Act entitled The Patient Protection and Affordable Care Act", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in helaht care spending, and for other purposes.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 1679, "To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. - S.1796, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3200, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3590, "An Act entitled The Patient Protection and Affordable Care Act", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in helaht care spending, and for other purposes.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 2 / S. 275, "To amend title XXI of the Social Security Act to extend and improve the Children's Health Insurance Program, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - Issues relating to the "Comparative Effectiveness Research Act of 2008", regarding all provisions. - "Affordable Health Choices Act- To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. - House Energy & Commerce Committee Discussion Draft, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3200, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - Chairman's Mark, "America's Healthy Future Act of 2009", (bill not yet introduced), regarding all provisions.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 2 / S. 275, "To amend title XXI of the Social Security Act to extend and improve the Children's Health Insurance Program, and for other purposes", regarding all provisions. - Issues relating to the "Comparative Effectiveness Research Act of 2008", regarding all provisions.
Pathway for Biosimilars Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 2 / S. 275, "To amend title XXI of the Social Security Act to extend and improve the Children's Health Insurance Program, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - Issues relating to the "Comparative Effectiveness Research Act of 2008", regarding all provisions. -"Affordable Health Choices Act- To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. -House Energy & Commerce Committee Discussion Draft, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions.
Pathway for Biosimilars Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 2 / S. 275, "To amend title XXI of the Social Security Act to extend and improve the Children's Health Insurance Program, and for other purposes", regarding all provisions. - Issues relating to the "Comparative Effectiveness Research Act of 2008", regarding all provisions.
Pathway for Biosimilars Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 1679, "To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. - S.1796, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3200, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3590, "An Act entitled The Patient Protection and Affordable Care Act", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in helaht care spending, and for other purposes.
Pathway for Biosimilars Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 2 / S. 275, "To amend title XXI of the Social Security Act to extend and improve the Children's Health Insurance Program, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - Issues relating to the "Comparative Effectiveness Research Act of 2008", regarding all provisions. - "Affordable Health Choices Act- To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. - House Energy & Commerce Committee Discussion Draft, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3200, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - Chairman's Mark, "America's Healthy Future Act of 2009", (bill not yet introduced), regarding all provisions.
Pathway for Biosimilars Act
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 1679, "To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. - S.1796, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3200, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3590, "An Act entitled The Patient Protection and Affordable Care Act", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in helaht care spending, and for other purposes.
Healthy Workforce Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 2 / S. 275, "To amend title XXI of the Social Security Act to extend and improve the Children's Health Insurance Program, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - Issues relating to the "Comparative Effectiveness Research Act of 2008", regarding all provisions. -"Affordable Health Choices Act- To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. -House Energy & Commerce Committee Discussion Draft, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions.
Healthy Workforce Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 1679, "To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. - S.1796, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3200, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3590, "An Act entitled The Patient Protection and Affordable Care Act", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in helaht care spending, and for other purposes.
Healthy Workforce Act of 2009
Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 2 / S. 275, "To amend title XXI of the Social Security Act to extend and improve the Children's Health Insurance Program, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - Issues relating to the "Comparative Effectiveness Research Act of 2008", regarding all provisions. - "Affordable Health Choices Act- To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. - House Energy & Commerce Committee Discussion Draft, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3200, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - Chairman's Mark, "America's Healthy Future Act of 2009", (bill not yet introduced), regarding all provisions.
- Korea-US Free Trade Agreement
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2011 · first_quarter · Q1
- Korea-US Free Trade Agreement
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2010 · fourth_quarter · Q4
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetamine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.
- H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 3397, "An Act to Amend the Controlled Substances Act to provide for take-back Disposal of Controlled Substances in certain instances and for other purposes", regarding all provisions. - H.R. 6331, "Generating Antibiotic Incentives Now Act of 2010", regarding all provisions.
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions. - H.R. 3790, "To amend Title XVIII of the Social Security Act to repeal the Medicare competitive acquision program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner. - H.R. 5440, "The Genomics and Personalized Medicine Act of 2010", regarding all provisions. - H. R. 6331, "Generating Antibiotic Incentives Act of 2010", regarding all provisions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2010 · third_quarter · Q3
- H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 3397, "An Act to Amend the Controlled Substances Act to provide for take-back Disposal of Controlled Substances in certain instances and for other purposes", regarding all provisions.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetimine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions. - H.R. 3790, "To amend Title XVIII of the Social Security Act to repeal the Medicare competitive acquision program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner. - H.R. 5440, "The Genomics and Personalized Medicine Act of 2010", regarding all provisions. - H. R. 6331, "Generating Antibiotic Incentives Act of 2010", regarding all provisions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2010 · second_quarter · Q2
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346/ S. 540, "Medical Device Safety Act of 2009", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications.
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions. - H.R. 3790, "To amend Title XVIII of the Social Security Act to repeal the Medicare competitive acquision program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner. - H.R. 5440, "The Genomics and Personalized Medicine Act of 2010", regarding all provisions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2010 · first_quarter · Q1
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - H.R. 3590, "An Act entitled The Patient Protection and Affordable Care Act", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 4872, "Health Care and Education Reconciliation Act of 2010", regarding all provisions.
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2009 · fourth_quarter · 4A
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 1679, "To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. - S.1796, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3200, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3590, "An Act entitled The Patient Protection and Affordable Care Act", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in helaht care spending, and for other purposes.
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2009 · fourth_quarter · Q4
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions. - H.R. 3790, "To amend Title XVIII of the Social Security Act to repeal the Medicare competitive acquision program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions.
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2009 · third_quarter · Q3
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 2 / S. 275, "To amend title XXI of the Social Security Act to extend and improve the Children's Health Insurance Program, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - Issues relating to the "Comparative Effectiveness Research Act of 2008", regarding all provisions. - "Affordable Health Choices Act- To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. - House Energy & Commerce Committee Discussion Draft, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3200, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - Chairman's Mark, "America's Healthy Future Act of 2009", (bill not yet introduced), regarding all provisions.
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2009 · second_quarter · Q2
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 2 / S. 275, "To amend title XXI of the Social Security Act to extend and improve the Children's Health Insurance Program, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - Issues relating to the "Comparative Effectiveness Research Act of 2008", regarding all provisions. -"Affordable Health Choices Act- To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. -House Energy & Commerce Committee Discussion Draft, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions.
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2009 · first_quarter · Q1
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions.
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 2 / S. 275, "To amend title XXI of the Social Security Act to extend and improve the Children's Health Insurance Program, and for other purposes", regarding all provisions. - Issues relating to the "Comparative Effectiveness Research Act of 2008", regarding all provisions.
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2008 · fourth_quarter · 4A
-Issues regarding bilateral free trade agreements with South Korea, Peru, Columbia, and Panama; -S. 2731, "Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008", A bill to authorize appropriations for fiscal years 2009 through 2013 to provide assistance to foreign countries to combat HIV/AIDS, tuberculosis, and malaria, and for other purposes, regarding all provisions.
-H.R. 1190, "Community Cancer Care Preservation Act of 2007," regarding amending title XVIII of the Social Security Act to preserve access to community cancer care by Medicare beneficiaries; -Proposed Rule (CMS-1404-P), "CY 2009 Outpatient Prospective Payment System Rules". -H.R. 1321,Medicare Advanced Laboratory Diagnostics Act of 2007, regarding amending title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule; -H.R. 1663, Medicare Mental Health Modernization Act of 2007, regarding amending title XVIII of the Social Security Act to expand and improve coverage of mental health services under the Medicare Program; -H.R. 1845 / S 1428, Medicare Durable Medical Equipment Access Act of 2007, regarding amending part B of title XVIII of the Social Security Act to assure access to durable medical equipment under the Medicare Program; -H.R. 2770, To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price, all provisions; -H.R. 3011, To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program, regarding all provisions; -H.R. 3061, Medicare Part D Drug Class Protection Act of 2007, regarding amending title XVIII of the Social Security Act to require that Medicare prescription drug plans using formularies cover all drugs included in 6 specified therapeutic categories and to establish protective requirements for coverage determinations; -H.R. 4 / S 3, Medicare Prescription Drug Price Negotiation Act of 2007, regarding amending part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate lower covered part D drug prices on behalf of Medicare beneficiaries; -H.R. 976 / S 1893, Children's Health Insurance Program Reauthorization Act of 2007; -H.R. 3162, Children's Health and Medicare Protection Act of 2007, regarding improving enrollment and retention of eligible children; -S. 1887, Medicare Access to Critical Medications Act of 2007, regarding amending title XVIII of the Social Security Act in order to ensure access to critical medications under the Medicare part D prescription drug program; -S. 631, Remote Monitoring Access Act of 2007, regarding amending title XVIII of the Social Security Act to provide for coverage of remote patient management services for chronic health care conditions under the Medicare Program; -S. 860, Early Treatment for HIV Act of 2007, regarding amending title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV; -CMS-1270-F, Medicare Program; Competitive Acquisition for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) and Other Issues, regarding a final rule establishing competitive bidding programs for certain Medicare Part B covered items of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) throughout the United States in accordance with sections 1847(a) and (b) of the Social Security Act; issues regarding competitive bidding, demonstrations for clinical lab services and competitive Medicare payments for lab services; issues regarding Medicare national coverage determination for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions; -CMS-2238-FC, regarding the Medicaid program, and prescription drugs; -S. 2499, "Medicare, Medicaid, and SCHIP Extension Act of 2007," all provisions. -S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid or SCHIP; -H.R. 5765 / S. 631, "Medicare Remote Monitoring Access Act of 2008," regarding amending title XVIII of the Social Security Act to cover remote patient management services for certain chronic health conditions under the Medicare Program; -H.R. 6252, "Medicare DMEPOS Competitive Acquisition Reform Act of 2008", To amend part B of title XVIII of the Social Security Act to delay and reform the Medicare competitive acquisition program for purchase of durable medical equipment, prosthetics, orthotics, and supplies, regarding all provisions; -S. 2404, "Medicare Advanced Laboratory Diagnostics Act of 2007", A bill to amend title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule, regarding all provisions; -H.R. 6331/ S. 3101, "Medicare Improvements for Patients and Providers Act of 2008", A bill to amend titles XVIII and XI of the Social Security Act to extend expiring provisions under the Medicare program, to improve beneficiary access to preventive and mental health services, to enhance low-income benefit programs, and to maintain access to care in rural areas, including pharmacy access, and for other purposes, regarding all provisions; -H.R. 2770, "To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price", regarding all provisions.
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2008 · fourth_quarter · 4A
-H.R. 1908 / S. 1145, "Patent Reform Act of 2007," regarding amending title 35, United States Code, to provide for patent reform; -Thailand Compulsory License.
-H.R. 2762 / S. 1494, "To amend the Public Health Services Act to reauthorize the special diabetes program for Type 1 diabetes and Indians under the Act," regarding all provisions; -H.R. 2349/ S. 1413 "Uterine Fibroid Research and Education Act of 2007", To provide research and education with respect to uterine fibroids, and for other purposes, regarding all provisions.
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2008 · fourth_quarter · Q4
-H.R. 1190, "Community Cancer Care Preservation Act of 2007," regarding amending title XVIII of the Social Security Act to preserve access to community cancer care by Medicare beneficiaries; -Proposed Rule (CMS-1404-P), "CY 2009 Outpatient Prospective Payment System Rules". -H.R. 1321,Medicare Advanced Laboratory Diagnostics Act of 2007, regarding amending title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule; -H.R. 1663, Medicare Mental Health Modernization Act of 2007, regarding amending title XVIII of the Social Security Act to expand and improve coverage of mental health services under the Medicare Program; -H.R. 1845 / S 1428, Medicare Durable Medical Equipment Access Act of 2007, regarding amending part B of title XVIII of the Social Security Act to assure access to durable medical equipment under the Medicare Program; -H.R. 2770, To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price, all provisions; -H.R. 3011, To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program, regarding all provisions; -H.R. 3061, Medicare Part D Drug Class Protection Act of 2007, regarding amending title XVIII of the Social Security Act to require that Medicare prescription drug plans using formularies cover all drugs included in 6 specified therapeutic categories and to establish protective requirements for coverage determinations; -H.R. 4 / S 3, Medicare Prescription Drug Price Negotiation Act of 2007, regarding amending part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate lower covered part D drug prices on behalf of Medicare beneficiaries; -H.R. 976 / S 1893, Children's Health Insurance Program Reauthorization Act of 2007; -H.R. 3162, Children's Health and Medicare Protection Act of 2007, regarding improving enrollment and retention of eligible children; -S. 1887, Medicare Access to Critical Medications Act of 2007, regarding amending title XVIII of the Social Security Act in order to ensure access to critical medications under the Medicare part D prescription drug program; -S. 631, Remote Monitoring Access Act of 2007, regarding amending title XVIII of the Social Security Act to provide for coverage of remote patient management services for chronic health care conditions under the Medicare Program; -S. 860, Early Treatment for HIV Act of 2007, regarding amending title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV; -CMS-1270-F, Medicare Program; Competitive Acquisition for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) and Other Issues, regarding a final rule establishing competitive bidding programs for certain Medicare Part B covered items of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) throughout the United States in accordance with sections 1847(a) and (b) of the Social Security Act; issues regarding competitive bidding, demonstrations for clinical lab services and competitive Medicare payments for lab services; issues regarding Medicare national coverage determination for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions; -CMS-2238-FC, regarding the Medicaid program, and prescription drugs; -S. 2499, "Medicare, Medicaid, and SCHIP Extension Act of 2007," all provisions. -S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid or SCHIP; -H.R. 5765 / S. 631, "Medicare Remote Monitoring Access Act of 2008," regarding amending title XVIII of the Social Security Act to cover remote patient management services for certain chronic health conditions under the Medicare Program; -H.R. 6252, "Medicare DMEPOS Competitive Acquisition Reform Act of 2008", To amend part B of title XVIII of the Social Security Act to delay and reform the Medicare competitive acquisition program for purchase of durable medical equipment, prosthetics, orthotics, and supplies, regarding all provisions; -S. 2404, "Medicare Advanced Laboratory Diagnostics Act of 2007", A bill to amend title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule, regarding all provisions; -H.R. 6331/ S. 3101, "Medicare Improvements for Patients and Providers Act of 2008", A bill to amend titles XVIII and XI of the Social Security Act to extend expiring provisions under the Medicare program, to improve beneficiary access to preventive and mental health services, to enhance low-income benefit programs, and to maintain access to care in rural areas, including pharmacy access, and for other purposes, regarding all provisions; -H.R. 2770, "To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price", regarding all provisions.
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2008 · third_quarter · Q3
-H.R. 3043 / S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations; -H.R. 3161 / S. 1859, "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008," regarding drug importation; -H. Con. Res. 99, "Revising the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 though 2012," regarding healthcare funding issues.
-Issues regarding bilateral free trade agreements with South Korea, Peru, Columbia, and Panama; -S. 2731, "Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008", A bill to authorize appropriations for fiscal years 2009 through 2013 to provide assistance to foreign countries to combat HIV/AIDS, tuberculosis, and malaria, and for other purposes, regarding all provisions.
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2008 · second_quarter · Q2
H.R. 1190, "Community Cancer Care Preservation Act of 2007," regarding amending title XVIII of the Social Security Act to preserve access to community cancer care by Medicare beneficiaries; HR 1321,Medicare Advanced Laboratory Diagnostics Act of 2007, regarding amending title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule; HR 1663, Medicare Mental Health Modernization Act of 2007, regarding amending title XVIII of the Social Security Act to expand and improve coverage of mental health services under the Medicare Program; HR 1845 / S 1428, Medicare Durable Medical Equipment Access Act of 2007, regarding amending part B of title XVIII of the Social Security Act to assure access to durable medical equipment under the Medicare Program; HR 2770, To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price, all provisions; HR 3011, To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program, regarding all provisions; HR 3061, Medicare Part D Drug Class Protection Act of 2007, regarding amending title XVIII of the Social Security Act to require that Medicare prescription drug plans using formularies cover all drugs included in 6 specified therapeutic categories and to establish protective requirements for coverage determinations; HR 4 / S 3, Medicare Prescription Drug Price Negotiation Act of 2007, regarding amending part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate lower covered part D drug prices on behalf of Medicare beneficiaries; HR 976 / S 1893, Children's Health Insurance Program Reauthorization Act of 2007; HR 3162, Children's Health and Medicare Protection Act of 2007, regarding improving enrollment and retention of eligible children; S 1887, Medicare Access to Critical Medications Act of 2007, regarding amending title XVIII of the Social Security Act in order to ensure access to critical medications under the Medicare part D prescription drug program; S 631, Remote Monitoring Access Act of 2007, regarding amending title XVIII of the Social Security Act to provide for coverage of remote patient management services for chronic health care conditions under the Medicare Program; S 860, Early Treatment for HIV Act of 2007, regarding amending title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV; CMS-1270-F, Medicare Program; Competitive Acquisition for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) and Other Issues, regarding a final rule establishing competitive bidding programs for certain Medicare Part B covered items of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) throughout the United States in accordance with sections 1847(a) and (b) of the Social Security Act; issues regarding competitive bidding, demonstrations for clinical lab services and competitive Medicare payments for lab services; issues regarding Medicare national coverage determination for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions; CMS-2238-FC, regarding the Medicaid program, and prescription drugs; S 2499, "Medicare, Medicaid, and SCHIP Extension Act of 2007," all provisions. S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid or SCHIP; H.R. 5765 / S. 631, "Medicare Remote Monitoring Access Act of 2008," regarding amending title XVIII of the Social Security Act to cover remote patient management services for certain chronic health conditions under the Medicare Program; H.R. 6252, "To amend part B of title XVIII of the Social Security Act to delay and reform the Medicare competitive acquisition program for purchase of durable medical equipment, prosthetics, orthotics, and supplies", regarding all provisions; S. 2404, "A bill to amend title SVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule", regarding all provisions; H.R. 6331/ S. 3101, "A bill to amend titles XVIII and XIX of the Social Security Act to extend expiring provisions under the Medicare program, to improve beneficiary access to preventive and mental health services, to enhance low-income benefit programs, and to maintain access to care in rural areas, including pharmacy access, and for other purposes", regarding all provisions.
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2008 · first_quarter · Q1
H.R. 1190, "Community Cancer Care Preservation Act of 2007," regarding amending title XVIII of the Social Security Act to preserve access to community cancer care by Medicare beneficiaries; HR 1321,Medicare Advanced Laboratory Diagnostics Act of 2007, regarding amending title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule; HR 1663, Medicare Mental Health Modernization Act of 2007, regarding amending title XVIII of the Social Security Act to expand and improve coverage of mental health services under the Medicare Program; HR 1845 / S 1428, Medicare Durable Medical Equipment Access Act of 2007, regarding amending part B of title XVIII of the Social Security Act to assure access to durable medical equipment under the Medicare Program; HR 2770, To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price, all provisions; HR 3011, To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program, regarding all provisions; HR 3061, Medicare Part D Drug Class Protection Act of 2007, regarding amending title XVIII of the Social Security Act to require that Medicare prescription drug plans using formularies cover all drugs included in 6 specified therapeutic categories and to establish protective requirements for coverage determinations; HR 4 / S 3, Medicare Prescription Drug Price Negotiation Act of 2007, regarding amending part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate lower covered part D drug prices on behalf of Medicare beneficiaries; HR 976 / S 1893, Children's Health Insurance Program Reauthorization Act of 2007; HR 3162, Children's Health and Medicare Protection Act of 2007, regarding improving enrollment and retention of eligible children; S 1887, Medicare Access to Critical Medications Act of 2007, regarding amending title XVIII of the Social Security Act in order to ensure access to critical medications under the Medicare part D prescription drug program; S 631, Remote Monitoring Access Act of 2007, regarding amending title XVIII of the Social Security Act to provide for coverage of remote patient management services for chronic health care conditions under the Medicare Program; S 860, Early Treatment for HIV Act of 2007, regarding amending title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV; CMS-1270-F, Medicare Program; Competitive Acquisition for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) and Other Issues, regarding a final rule establishing competitive bidding programs for certain Medicare Part B covered items of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) throughout the United States in accordance with sections 1847(a) and (b) of the Social Security Act; issues regarding competitive bidding, demonstrations for clinical lab services and competitive Medicare payments for lab services; issues regarding Medicare national coverage determination for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions; CMS-2238-FC, regarding the Medicaid program, and prescription drugs; S 2499, "Medicare, Medicaid, and SCHIP Extension Act of 2007," all provisions. S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid or SCHIP; H.R. 5765 / S. 631, "Medicare Remote Monitoring Access Act of 2008," regarding amending title XVIII of the Social Security Act to cover remote patient management services for certain chronic health conditions under the Medicare Program.
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2007 · year_end · YY
HR 3610, "Food and Drug Import Safety Act of 2007," regarding fees related to food safety.
HR 3043 / S 1710, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008, regarding appropriations; HR 3161 / S 1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008, regarding drug importation;
HR 1712, Research and Development Tax Credit Act of 2007, regarding amending the Internal Revenue Code of 1986 to provide incentives to improve America's research competitiveness;
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2007 · mid_year · MM
HR 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007,” regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; HR 1494 / S 830, “Pediatric Medical Device Safety and Improvement Act of 2007,” regarding improving the process for the development of needed pediatric medical devices; HR 1956, “Patient Protection and Innovative Biologic Medicines Act of 2007,” regarding amending the Public Health Service Act to provide for the approval of similar biological products; HR 2193, “Animal Protection Accountability Improvement Act,” regarding amending the Animal Welfare Act to increase the penalties for violations of such Act and to prohibit the use of animals for marketing medical devices; HR 2349 / S 1413, “Uterine Fibroid Research and Education Act of 2007,” regarding providing for research and education with respect to uterine fibroids; HR 3333 / S. 1576, “Minority Health Improvement and Health Disparity Elimination Act,” regarding amending the Public Health Service Act to improve the health and healthcare of racial and ethnic minority groups; HR 788 / S 468, “Food and Drug Administration Safety Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; HR 2900, “Food and Drug Administration Amendments Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; S 1082, “Food and Drug Administration Revitalization Act,” regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; S 1695, “Biologics Price Competition and Innovation Act of 2007,” regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products and to promote innovation in the life sciences; S 467, “Fair Access to Clinical Trials Act of 2007 or the `FACT Act',” regarding amending the Public Health Service Act to expand the clinical trials drug data bank; S 558, “Mental Health Parity Act of 2007,” regarding all provisions; S 628, “Critical Access to Health Information Technology Act of 2007,” regarding providing grants for rural health information technology development activities; S 993, “Pediatric Research Improvement Act,” regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine. HR 1165, “Swift Approval, Full Evaluation Drug Act or the `SAFE Drug Act',” regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals;
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2006 · year_end · YY
Competitive Bidding for DME Implementation of DRA In-Vitro Diagnostics Legislation Medicare Competitive Acquistion Program (CAP) Medicare Competitive Bidding for Durable Medical Equipment Medicare Fraud and Abuse Medicare Part B Drug Payment Reform Medicare Part D Implementation Medicare Payment Policy Medicare Hospital Outpatient Rule Medicare Pay for Performance - Inpatient Prospective Payment System - Proposed Rule Medicare Coverage of I-BOT Medicaid Reform Mental Health Limitation for Scientific Products Pain Management Legislation Physician Fee Schedule Rule Out Patient Physician System Self-Administration Rule HR 328, HR 376, S 334, S 813 - Medicare Prescription Drug Coverage and Pricing Information HR 4157 - HIT/ICD-10 Coding HR 5179 - Amend Title XVIII of Social Security Act HR 5369 - Advanced Laboratory Diagnostics Act of 2006 HR 5465, S 340 Community Cancer Care Preservation Act of 2006 HR 6063- Remote Monitoring Legislation S 239, S 445 - Medicare Prescription Druge Coverage and Pricing Non-Interference AIDS Drugs Assistance Program Appropriations Chronic Care Improvement Program (CCIP) Clinical Lab Fee Schedule Reimbursement Rates Competitive Bidding for Laboratory Services
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2005 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.
2004 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions. - H.R. 3790, "To amend Title XVIII of the Social Security Act to repeal the Medicare competitive acquision program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner.
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions.
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions. - H.R. 3790, "To amend Title XVIII of the Social Security Act to repeal the Medicare competitive acquision program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 1679, "To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. - S.1796, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3200, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3590, "An Act entitled The Patient Protection and Affordable Care Act", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in helaht care spending, and for other purposes.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions.
- S. Con. Res. 13, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2010, revising the appropriate budgetary levels for fiscal year 2009, and setting forth the appropriate budgetary levels for fiscal years 2011 through 2014.", regarding all provisions. - H. Con. Res. 85, "Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.", regarding all provisions.
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions.
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions.
- S. Con. Res. 13, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2010, revising the appropriate budgetary levels for fiscal year 2009, and setting forth the appropriate budgetary levels for fiscal years 2011 through 2014.", regarding all provisions. - H. Con. Res. 85, "Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.", regarding all provisions.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
-S. 1, "A bill to create jobs, restore economic growth, and strengthen America's middle class through measures that modernize the nation's infrastructure, enhance America's energy independence, expand educational opportunities, preserve and improve affordable health care, provide tax relief, and protect those in greatest need, and for other purposes", regarding all provisions. - H.R. 1, "Making supplemental appropriations for job preservation and creation, infrastructure investment, energy efficiency and science, assistance to the unemployed, and State and local fiscal stabilization, for fiscal year ending September 30, 2009, and for other purposes", regarding all provisions. - S. Con. Res. 13, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2010, revising the appropriate budgetary levels for fiscal year 2009, and setting forth the appropriate budgetary levels for fiscal years 2011 through 2014.", regarding all provisions. - H. Con. Res. 85, "Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.", regarding all provisions.
- S. 301, "A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP", regarding all provisions.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
-H.R. 3043 / S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations; -H.R. 3161 / S. 1859, "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008," regarding drug importation; -H. Con. Res. 99, "Revising the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 though 2012," regarding healthcare funding issues.
-H.R. 1908 / S. 1145, "Patent Reform Act of 2007," regarding amending title 35, United States Code, to provide for patent reform; -Thailand Compulsory License.
-H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; -H.R. 1494 / S. 830, "Pediatric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediatric medical devices; -H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; -H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; -H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; -H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; -H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; -H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; -S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; -S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; -S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; -S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; -S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; -S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; -H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; -H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; -H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; -S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; -H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; -H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products; -H.R. 5839, "Safeguarding America's Pharmaceuticals Act of 2008", To Amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs, regarding all provisions; -S. 334, "Healthy Americans Act", A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away, regarding all provisions; -H.R. 6381, "Medical Device Safety Act of 2008", To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions; -S. 438, "Fair Prescription Drug Competition Act", A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs, regarding all provisions; -S.2274, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan", and for other purposes, regarding all provisions. -S.3409 "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration", and for other purposes; regarding all provisions. -S.1378 "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan", and for other purposes; regarding all provisions. -S. 3408, "Comparative Effectiveness Research Act of 2008", A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes, regarding all provisions; -S. 1276, "Methamphetamine Production Prevention Act of 2008", A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions. -Proposed Rule (CMS-1403-P), Regarding revisions to Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions; -S.2424, "A bill to ensure that all Americans have basic health literacy skills to function effectively as patients and health care consumers", regarding all provisions.
-H.R. 2762 / S. 1494, "To amend the Public Health Services Act to reauthorize the special diabetes program for Type 1 diabetes and Indians under the Act," regarding all provisions; -H.R. 2349/ S. 1413 "Uterine Fibroid Research and Education Act of 2007", To provide research and education with respect to uterine fibroids, and for other purposes, regarding all provisions.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
-H.R. 3043 / S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations; -H.R. 3161 / S. 1859, "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008," regarding drug importation; -H. Con. Res. 99, "Revising the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 though 2012," regarding healthcare funding issues.
-H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; -H.R. 1494 / S. 830, "Pediatric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediatric medical devices; -H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; -H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; -H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; -H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; -H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; -H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; -S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; -S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; -S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; -S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; -S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; -S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; -H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; -H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; -H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; -S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; -H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; -H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products; -H.R. 5839, "Safeguarding America's Pharmaceuticals Act of 2008", To Amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs, regarding all provisions; -S. 334, "Healthy Americans Act", A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away, regarding all provisions; -H.R. 6381, "Medical Device Safety Act of 2008", To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions; -S. 438, "Fair Prescription Drug Competition Act", A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs, regarding all provisions; -S.2274, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan", and for other purposes, regarding all provisions. -S.3409 "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration", and for other purposes; regarding all provisions. -S.1378 "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan", and for other purposes; regarding all provisions. -S. 3408, "Comparative Effectiveness Research Act of 2008", A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes, regarding all provisions; -S. 1276, "Methamphetamine Production Prevention Act of 2008", A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions. -Proposed Rule (CMS-1403-P), Regarding revisions to Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions; -S.2424, "A bill to ensure that all Americans have basic health literacy skills to function effectively as patients and health care consumers", regarding all provisions.
-H.R. 1190, "Community Cancer Care Preservation Act of 2007," regarding amending title XVIII of the Social Security Act to preserve access to community cancer care by Medicare beneficiaries; -Proposed Rule (CMS-1404-P), "CY 2009 Outpatient Prospective Payment System Rules". -H.R. 1321,Medicare Advanced Laboratory Diagnostics Act of 2007, regarding amending title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule; -H.R. 1663, Medicare Mental Health Modernization Act of 2007, regarding amending title XVIII of the Social Security Act to expand and improve coverage of mental health services under the Medicare Program; -H.R. 1845 / S 1428, Medicare Durable Medical Equipment Access Act of 2007, regarding amending part B of title XVIII of the Social Security Act to assure access to durable medical equipment under the Medicare Program; -H.R. 2770, To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price, all provisions; -H.R. 3011, To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program, regarding all provisions; -H.R. 3061, Medicare Part D Drug Class Protection Act of 2007, regarding amending title XVIII of the Social Security Act to require that Medicare prescription drug plans using formularies cover all drugs included in 6 specified therapeutic categories and to establish protective requirements for coverage determinations; -H.R. 4 / S 3, Medicare Prescription Drug Price Negotiation Act of 2007, regarding amending part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate lower covered part D drug prices on behalf of Medicare beneficiaries; -H.R. 976 / S 1893, Children's Health Insurance Program Reauthorization Act of 2007; -H.R. 3162, Children's Health and Medicare Protection Act of 2007, regarding improving enrollment and retention of eligible children; -S. 1887, Medicare Access to Critical Medications Act of 2007, regarding amending title XVIII of the Social Security Act in order to ensure access to critical medications under the Medicare part D prescription drug program; -S. 631, Remote Monitoring Access Act of 2007, regarding amending title XVIII of the Social Security Act to provide for coverage of remote patient management services for chronic health care conditions under the Medicare Program; -S. 860, Early Treatment for HIV Act of 2007, regarding amending title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV; -CMS-1270-F, Medicare Program; Competitive Acquisition for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) and Other Issues, regarding a final rule establishing competitive bidding programs for certain Medicare Part B covered items of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) throughout the United States in accordance with sections 1847(a) and (b) of the Social Security Act; issues regarding competitive bidding, demonstrations for clinical lab services and competitive Medicare payments for lab services; issues regarding Medicare national coverage determination for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions; -CMS-2238-FC, regarding the Medicaid program, and prescription drugs; -S. 2499, "Medicare, Medicaid, and SCHIP Extension Act of 2007," all provisions. -S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid or SCHIP; -H.R. 5765 / S. 631, "Medicare Remote Monitoring Access Act of 2008," regarding amending title XVIII of the Social Security Act to cover remote patient management services for certain chronic health conditions under the Medicare Program; -H.R. 6252, "Medicare DMEPOS Competitive Acquisition Reform Act of 2008", To amend part B of title XVIII of the Social Security Act to delay and reform the Medicare competitive acquisition program for purchase of durable medical equipment, prosthetics, orthotics, and supplies, regarding all provisions; -S. 2404, "Medicare Advanced Laboratory Diagnostics Act of 2007", A bill to amend title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule, regarding all provisions; -H.R. 6331/ S. 3101, "Medicare Improvements for Patients and Providers Act of 2008", A bill to amend titles XVIII and XI of the Social Security Act to extend expiring provisions under the Medicare program, to improve beneficiary access to preventive and mental health services, to enhance low-income benefit programs, and to maintain access to care in rural areas, including pharmacy access, and for other purposes, regarding all provisions; -H.R. 2770, "To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price", regarding all provisions.
-Issues regarding bilateral free trade agreements with South Korea, Peru, Columbia, and Panama; -S. 2731, "Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008", A bill to authorize appropriations for fiscal years 2009 through 2013 to provide assistance to foreign countries to combat HIV/AIDS, tuberculosis, and malaria, and for other purposes, regarding all provisions.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
-H.R. 2762 / S. 1494, "To amend the Public Health Services Act to reauthorize the special diabetes program for Type 1 diabetes and Indians under the Act," regarding all provisions; -H.R. 2349/ S. 1413 "Uterine Fibroid Research and Education Act of 2007", To provide research and education with respect to uterine fibroids, and for other purposes, regarding all provisions.
-H.R. 1908 / S. 1145, "Patent Reform Act of 2007," regarding amending title 35, United States Code, to provide for patent reform; -Thailand Compulsory License.
-H.R. 3043 / S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations; -H.R. 3161 / S. 1859, "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008," regarding drug importation; -H. Con. Res. 99, "Revising the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 though 2012," regarding healthcare funding issues.
-H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; -H.R. 1494 / S. 830, "Pediatric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediatric medical devices; -H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; -H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; -H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; -H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; -H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; -H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; -S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; -S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; -S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; -S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; -S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; -S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; -H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; -H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; -H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; -S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; -H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; -H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products; -H.R. 5839, "Safeguarding America's Pharmaceuticals Act of 2008", To Amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs, regarding all provisions; -S. 334, "Healthy Americans Act", A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away, regarding all provisions; -H.R. 6381, "Medical Device Safety Act of 2008", To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions; -S. 438, "Fair Prescription Drug Competition Act", A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs, regarding all provisions; -S.2274, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan", and for other purposes, regarding all provisions. -S.3409 "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration", and for other purposes; regarding all provisions. -S.1378 "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan", and for other purposes; regarding all provisions. -S. 3408, "Comparative Effectiveness Research Act of 2008", A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes, regarding all provisions; -S. 1276, "Methamphetamine Production Prevention Act of 2008", A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions. -Proposed Rule (CMS-1403-P), Regarding revisions to Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions; -S.2424, "A bill to ensure that all Americans have basic health literacy skills to function effectively as patients and health care consumers", regarding all provisions.
-Issues regarding bilateral free trade agreements with South Korea, Peru, Columbia, and Panama; -S. 2731, "Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008", A bill to authorize appropriations for fiscal years 2009 through 2013 to provide assistance to foreign countries to combat HIV/AIDS, tuberculosis, and malaria, and for other purposes, regarding all provisions.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
-H.R.1165, "Swift Approval, Full Evaluation Drug Act or the 'SAFE Drug Act," regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals; -H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; -H.R. 1494 / S. 830, "Pediatric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediatric medical devices; -H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; -H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; -H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; -H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; -H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; -H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; -S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; -S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; -S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; -S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; -S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; -S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; -H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; -H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; -H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; -S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; -H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; -H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products; -H.R. 5839, "Safeguarding America's Pharmaceuticals Act of 2008", To Amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs, regarding all provisions; -S. 334, "Healthy Americans Act", A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away, regarding all provisions; -H.R. 6381, "Medical Device Safety Act of 2008", To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions; -S. 438, "Fair Prescription Drug Competition Act", A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs, regarding all provisions; -S. 3408, "Comparative Effectiveness Research Act of 2008", A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes, regarding all provisions; -S. 1276, "Methamphetamine Production Prevention Act of 2008", A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions. -Proposed Rule (CMS-1403-P), Regarding revisions to Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions;
-H.R. 2762 / S. 1494, "To amend the Public Health Services Act to reauthorize the special diabetes program for Type 1 diabetes and Indians under the Act," regarding all provisions; -H.R. 2349/ S. 1413 "Uterine Fibroid Research and Education Act of 2007", To provide research and education with respect to uterine fibroids, and for other purposes, regarding all provisions.
-H.R. 1190, "Community Cancer Care Preservation Act of 2007," regarding amending title XVIII of the Social Security Act to preserve access to community cancer care by Medicare beneficiaries; -Proposed Rule (CMS-1404-P), "CY 2009 Outpatient Prospective Payment System Rules". -H.R. 1321,Medicare Advanced Laboratory Diagnostics Act of 2007, regarding amending title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule; -H.R. 1663, Medicare Mental Health Modernization Act of 2007, regarding amending title XVIII of the Social Security Act to expand and improve coverage of mental health services under the Medicare Program; -H.R. 1845 / S 1428, Medicare Durable Medical Equipment Access Act of 2007, regarding amending part B of title XVIII of the Social Security Act to assure access to durable medical equipment under the Medicare Program; -H.R. 2770, To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price, all provisions; -H.R. 3011, To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program, regarding all provisions; -H.R. 3061, Medicare Part D Drug Class Protection Act of 2007, regarding amending title XVIII of the Social Security Act to require that Medicare prescription drug plans using formularies cover all drugs included in 6 specified therapeutic categories and to establish protective requirements for coverage determinations; -H.R. 4 / S 3, Medicare Prescription Drug Price Negotiation Act of 2007, regarding amending part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate lower covered part D drug prices on behalf of Medicare beneficiaries; -H.R. 976 / S 1893, Children's Health Insurance Program Reauthorization Act of 2007; -H.R. 3162, Children's Health and Medicare Protection Act of 2007, regarding improving enrollment and retention of eligible children; -S. 1887, Medicare Access to Critical Medications Act of 2007, regarding amending title XVIII of the Social Security Act in order to ensure access to critical medications under the Medicare part D prescription drug program; -S. 631, Remote Monitoring Access Act of 2007, regarding amending title XVIII of the Social Security Act to provide for coverage of remote patient management services for chronic health care conditions under the Medicare Program; -S. 860, Early Treatment for HIV Act of 2007, regarding amending title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV; -CMS-1270-F, Medicare Program; Competitive Acquisition for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) and Other Issues, regarding a final rule establishing competitive bidding programs for certain Medicare Part B covered items of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) throughout the United States in accordance with sections 1847(a) and (b) of the Social Security Act; issues regarding competitive bidding, demonstrations for clinical lab services and competitive Medicare payments for lab services; issues regarding Medicare national coverage determination for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions; -CMS-2238-FC, regarding the Medicaid program, and prescription drugs; -S. 2499, "Medicare, Medicaid, and SCHIP Extension Act of 2007," all provisions. -S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid or SCHIP; -H.R. 5765 / S. 631, "Medicare Remote Monitoring Access Act of 2008," regarding amending title XVIII of the Social Security Act to cover remote patient management services for certain chronic health conditions under the Medicare Program; -H.R. 6252, "Medicare DMEPOS Competitive Acquisition Reform Act of 2008", To amend part B of title XVIII of the Social Security Act to delay and reform the Medicare competitive acquisition program for purchase of durable medical equipment, prosthetics, orthotics, and supplies, regarding all provisions; -S. 2404, "Medicare Advanced Laboratory Diagnostics Act of 2007", A bill to amend title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule, regarding all provisions; -H.R. 6331/ S. 3101, "Medicare Improvements for Patients and Providers Act of 2008", A bill to amend titles XVIII and XI of the Social Security Act to extend expiring provisions under the Medicare program, to improve beneficiary access to preventive and mental health services, to enhance low-income benefit programs, and to maintain access to care in rural areas, including pharmacy access, and for other purposes, regarding all provisions; -H.R. 2770, "To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price", regarding all provisions.
-H.R. 1908 / S. 1145, "Patent Reform Act of 2007," regarding amending title 35, United States Code, to provide for patent reform; -Thailand Compulsory License.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 3043 / S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations; H.R. 3161 / S. 1859, "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008," regarding drug importation; H. Con. Res. 99, "Revising the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 though 2012," regarding healthcare funding issues.
H.R. 1908 / S. 1145, "Patent Reform Act of 2007," regarding amending title 35, United States Code, to provide for patent reform; Thailand Cumpulsory License.
H.R.1165, "Swift Approval, Full Evaluation Drug Act or the 'SAFE Drug Act," regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals; H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision o mental health and substance-related disorder benefits under group health plans; H.R. 1494 / S. 830, "Pediactric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediactric medical devices; H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products; H.R. 5839, "To Amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs", regarding all provisions; S. 334, "A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away", regarding all provisions; H.R. 6381, "To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions; S. 438, "A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs", regarding all provisions.
H.R. 2762 / S. 1494, "To amend the Public Health Services Act to reauthorize the special diabetes program for Type 1 diabetes and Indians under the Act," regarding all provisions; H.R. 2349/ S. 1413 "To provide research and education with respect to uterine fibroids, and for other purposes", regarding all provisions.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R. 2762 / S. 1494, "To amend the Public Health Services Act to reauthorize the special diabetes program for Type 1 diabetes and Indians under the Act," regarding all provisions.
H.R. 1908 / S. 1145, "Patent Reform Act of 2007," regarding amending title 35, United States Code, to provide for patent reform; Thailand Cumpulsory License.
H.R.1165, "Swift Approval, Full Evaluation Drug Act or the 'SAFE Drug Act," regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals; H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision o mental health and substance-related disorder benefits under group health plans; H.R. 1494 / S. 830, "Pediactric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediactric medical devices; H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products.
H.R. 3043 / S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations; H.R. 3161 / S. 1859, "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008," regarding drug importation; H. Con. Res. 99, "Revising the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 though 2012," regarding healthcare funding issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HR 1190, Community Cancer Care Preservation Act of 2007, regarding amending title XVIII of the Social Security Act to preserve access to community cancer care by Medicare beneficiaries;
S 1145, "Patent Reform Act of 2007;" HR 1908, Patent Reform Act of 2007, regarding amending title 35, United States Code, to provide for patent reform; Thailand Compulsory License.
Issues regarding bilateral free trade agreements with South Korea, Peru, Columbia and Panama.
HR 2762 / S 1494, To amend the Public Health Service Act to reauthorize the special diabetes programs for Type I diabetes and Indians under that Act, regarding all provisions.
HR 1165, Swift Approval, Full Evaluation Drug Act or the 'SAFE Drug Act', regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals;
HR 2589, Improving Pharmaceuticals for Children Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act;
S 635, Methamphetamine Remediation Research Act of 2007, regarding providing for a research program for remediation of closed methamphetamine production laboratories; issues regarding Federal judicial salaries.
HR 1591, U.S. Troop Readiness, Veterans' Health, and Iraq Accountability Appropriations Act, 2007, regarding Medicaid rebates; HR 1585, "National Defense Authorization Act for Fiscal Year 2008," regarding TRICARE.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S 41, “Research Competitiveness Act of 2007,” regarding amending the Internal Revenue Code of 1986 to provide incentives to improve America's research competitiveness. HR 1712, “Research and Development Tax Credit Act of 2007,” regarding amending the Internal Revenue Code of 1986 to provide incentives to improve America's research competitiveness; HR 763, “To amend the Internal Revenue Code of 1986 to make permanent the deduction allowable with respect to income attributable to domestic production activities in Puerto Rico,” all provisions;
Issues regarding bilateral free trade agreements with South Korea, Peru, Columbia and Panama.
H Con Res 99, "Revising the congressional budget for the United States Government for fiscal year 2007, establishing the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 through 2012," regarding healthcare funding issues. HR 3043 / S 1710, “Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008,” regarding appropriations; HR 3161 / S 1859, “Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008,” regarding drug importation;
S 242, “Pharmaceutical Market Access and Drug Safety Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; S 251, “Pharmaceutical Market Access Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs. HR 2589, “Improving Pharmaceuticals for Children Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act; S 1156, “Best Pharmaceuticals for Children Amendments of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program;
S 635, “Methamphetamine Remediation Research Act of 2007,” regarding providing for a research program for remediation of closed methamphetamine production laboratories; issues regarding Federal judicial salaries.
HR 2762 / S 1494, “To amend the Public Health Service Act to reauthorize the special diabetes programs for Type I diabetes and Indians under that Act,” all provisions; S 976, "Genomics and Personalized Medicine Act of 2007," all provisions; S 736, "Laboratory Test Improvement Act," all provisions.
HR 1663, “Medicare Mental Health Modernization Act of 2007,” regarding amending title XVIII of the Social Security Act to expand and improve coverage of mental health services under the Medicare Program; HR 1845 / S 1428, “Medicare Durable Medical Equipment Access Act of 2007,” regarding amending part B of title XVIII of the Social Security Act to assure access to durable medical equipment under the Medicare Program; HR 2770, “To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price,” all provisions; HR 3011, “To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program,” regarding all provisions; HR 3061, “Medicare Part D Drug Class Protection Act of 2007,” regarding amending title XVIII of the Social Security Act to require that Medicare prescription drug plans using formularies cover all drugs included in 6 specified therapeutic categories and to establish protective requirements for coverage determinations; HR 4 / S 3, “Medicare Prescription Drug Price Negotiation Act of 2007,” regarding amending part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate lower covered part D drug prices on behalf of Medicare beneficiaries; HR 976 / S 1893, “Children's Health Insurance Program Reauthorization Act of 2007,” regarding amending the Internal Revenue Code of 1986 to provide tax relief for small businesses; HR 3162, “Children's Health and Medicare Protection Act of 2007,” regarding improving enrollment and retention of eligible children; S 1887, “Medicare Access to Critical Medications Act of 2007,” regarding amending title XVIII of the Social Security Act in order to ensure access to critical medications under the Medicare part D prescription drug program; S 631, “Remote Monitoring Access Act of 2007,” regarding amending title XVIII of the Social Security Act to provide for coverage of remote patient management services for chronic health care conditions under the Medicare Program; S 860, “Early Treatment for HIV Act of 2007,” regarding amending title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV; CMS-1270-F, “Medicare Program; Competitive Acquisition for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) and Other Issues,” regarding a final rule establishing competitive bidding programs for certain Medicare Part B covered items of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) throughout the United States in accordance with sections 1847(a) and (b) of the Social Security Act; issues regarding competitive bidding, demonstrations for clinical lab services and competitive Medicare payments for lab services; issues regarding Medicare national coverage determination for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions; CMS-2238-FC, regarding the Medicaid program, and prescription drugs. HR 1190, “Community Cancer Care Preservation Act of 2007,” regarding amending title XVIII of the Social Security Act to preserve access to community cancer care by Medicare beneficiaries; HR 1321, “Medicare Advanced Laboratory Diagnostics Act of 2007,” regarding amending title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule;
HR 1591, “U.S. Troop Readiness, Veterans' Health, and Iraq Accountability Appropriations Act, 2007,” regarding medicaid rebates.
HR 1908, “Patent Reform Act of 2007,” regarding amending title 35, United States Code, to provide for patent reform; Thailand Compulsory License.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Authorized Generics Patent Reform Follow-On Biologics Hatch-Waxman Reform
HR 5384 - FY 2007 Agriculture Appropriations HCR 376, SCR 83 - FY 2007 Budget Resolution HR 5647, S 3708 - FY 2007 Labor, Health, Human Services Appropriations HR 5385, S 3708 - FY 2007 Military Quality of Life Appropriations
HR 1736, S 627 - R&D Tax Credit HR 2830 - Pension Protection Act of 2005
P.L. 109-2 - Class Action Reform HR 1038 - Multi-district Litigation Restoration Act of 2005 HR 4838 - Medical Malpractice Reform Act of 2006
Ryan White Reauthorization Act HR 575 - Say No to Drug Ads Act HR 810 - Stem Cell HR 870 - PhRMA Act of 2005 HR 1457 - Health Information Technology Act of 2005 HR 2090 - Food and Drug Administration Improvement Act of 2005 HR 3196, S 470 - Fair Access to Clinical Trails Act HR 3204 - Public Health Service Act HR 3696 - Medical Advertising Reform Act HR 4157, S 1418 - Health Information Technology S 1955 - Small Business Health Plans S 3546 - Dietary Supplement and Non-Prescription Drug Consumer Protection Act S 3807 - Enhancing Drug Safety and Innovation Act of 2006 S 3897 - Medicare Access & Data S 4098 - Pediatric Medical Device Safety and Improvement Act of 2006 FDA Regulation of Single-Use Device Re-Processing Hospital Group Purchasing Organizations Pediatric Medical Devices Pharmaceutical Reimportation
US-Korea FTA US-China Enforcement Legislation
HR 314, HR 1446, S 103 - Methamphetamine Abuse HR 3199, US Patriot Act Improvement and Reauthorization (Combat Methamphetamine Included)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office